Microparticles stimulate angiogenesis by inducing ELR+ CXC-chemokines in synovial fibroblasts
- 1 April 2011
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 15 (4), 756-762
- https://doi.org/10.1111/j.1582-4934.2010.01051.x
Abstract
Microparticles (MPs) are small membrane-vesicles that accumulate in the synovial fluids of patients with rheumatoid arthritis (RA). In the arthritic joints, MPs induce a pro-inflammatory and invasive phenotype in synovial fibroblasts (SFs). The present study investigated whether activation of SFs by MPs stimulates angiogenesis in the inflamed joints of patients with RA. MPs were isolated from Jurkat cells and U937 cells by differential centrifugation. SFs were co-cultured with increasing numbers of MPs. The effects of supernatants from co-cultures on endothelial cells were studied in vitro and in vivo using MTT assays, annexin V and propidium iodide staining, trans-well migration assays and modified matrigel pouch assays. MPs strongly induced the expression of the pro-angiogenic ELR⁺ chemokines CXCL1, CXCL2, CXCL3, CXCL5 and CXCL6 in RASFs. Other vascular growth factors were not induced. Supernatants from co-cultures enhanced the migration of endothelial cells, which could be blocked by neutralizing antibodies against ELR⁺ chemokines. Consistent with the specific induction of ELR⁺ chemokines, proliferation and viability of endothelial cells were not affected by the supernatants. In the in vivo bio-chamber assay, supernatants from RASFs co-cultured with MPs stimulated angiogenesis with a significant increase of vessels infiltrating into the matrigel chamber. We demonstrated that MPs activate RASFs to release pro-angiogenic ELR⁺ chemokines. These pro-angiogenic mediators enhance migration of endothelial cells and stimulate the formation of new vessels. Our data suggest that MPs may contribute to the hypervascularization of inflamed joints in patients with rheumatoid arthritisKeywords
This publication has 27 references indexed in Scilit:
- Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functionsin vitroandin vivoJournal of Cellular and Molecular Medicine, 2009
- The vasculature in rheumatoid arthritis: cause or consequence?International Journal of Experimental Pathology, 2009
- Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytesArthritis Research & Therapy, 2009
- Rho‐associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblastsArthritis & Rheumatism, 2008
- Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individualsAnnals Of The Rheumatic Diseases, 2007
- Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosisArthritis Research & Therapy, 2007
- Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseasesArthritis & Rheumatism, 2005
- The release of microparticles by apoptotic cells and their effects on macrophagesApoptosis, 2005
- Expression of interleukin‐21 receptor, but not interleukin‐21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritisArthritis & Rheumatism, 2004
- ANGIOGENIC FACTOR FROM SYNOVIAL FLUID RESEMBLING THAT FROM TUMOURSThe Lancet, 1980